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Staphylococcus aureus, a well-documented human and animal
opportunistic pathogen, plays a signi¢cant role in nosocomial
infection, being a major cause of morbidity and mortality.
AccordingtoPerlandGolub1998[1], theprevalenceofStaphylo-
coccusaureusnasal carriage in humans is estimated tobe 20^25%,
varyingamongdi¡erentpopulations,byage,underlyingillness,
race, certain behaviors, and the living environment. The vast
majorityofS.aureus infectionsarecausedbystrainsbelongingto
thepatient'sown£ora. Inthe lastdecades, resistance andreduced
susceptibility to antimicrobial agents has become amajor noso-
comial concern. In particular, colonization of patients with
methicillin-resistant or/and reduced vancomycin-susceptible
S.aureus isanimportantfactorinhealthcare[2^4].
The occurrence of antibiotic-resistant microbes is recog-
nized to be strictly related to the extended use and misuse of
antibiotics. Almost half of the antibiotics now used in the
developed countries are used in agriculture, including many
antibiotics designed to treat human illness (for a review see
Gustafson and Bowen [5]).This use can foster antibiotic resis-
tance in bacteria which are common in animals and that cause
disease in humans [6, 7]. Aworldwide e¡ort to end the use in
livestock and animal feeds of antibiotics that are used in
human medicine has led in recent years to a restriction in the
use of antibiotics in agriculture. In1999, the Swiss government
prohibited the use of antimicrobial agents as probiotic com-
pounds, allowing their use as therapeutic agents only.
While abundant literature is available on themedical conse-
quences of resistance acquisition of animal origin for patho-
gens such as Salmonella, Campylobacter, enterococci and
Escherichia coli, little is known of the di¡erences in antibiotic
resistance between S. aureus strains from the human and the
animal reservoir. In our region, local dairy products, in parti-
cular typical fresh cheese (`formaggini'), are the major source
of Staphylococcus aureus food isolates. Although strongly
recommended by public health o¤cials and agricultural con-
sultants, thermal treatment of rawmilk (15min at 65 C) prior
to cheese production is not executed by at least 40% of cheese
producers, mainly due to antipathy towards `modern techni-
ques'. For this reason, a large proportion of such diary products
is contaminated with Staphylococcus aureus, one of the major
etiologic agents of bovinemastitis.
In this report we describe the evolution of antimicrobial
susceptibility and the relationship between clinical and food
isolates of Staphylococcus aureus in the last decade in the south-
ern part of Switzerland.
In total, 224 Staphylococcus aureus isolates were collected dur-
ing three clinical campaigns (159 isolates) and two food cam-
paigns (65 isolates). The clinical campaigns, lasting 2 months
each, were commissioned by GlaxoWellcome and carried out
at the local institute formedical microbiology (Istituto Canto-
nale Batteriosierologico): all Staphylococcus aureus isolates from
clinical samples were collected.The food campaigns, also last-
ing 2 months each, were performed as a routine food control
by the local food control authority (Laboratorio Cantonale):
again, all Staphylococcus aureus isolates recovered from contami-
nated dairy products (mainly `formaggini') were collected.
The evolution of antimicrobial susceptibility was moni-
tored with the disk di¡usion test, and the zone of inhibition
was interpreted according to NCCLS recommendations. The
array of antimicrobials included antibiotics currently used in
the treatment of both human and cattle infections: penicillin,
ampicillin, oxacillin, cefazolin, gentamicin, doxycycline, ery-
thromycin, vancomycin, trimethoprim/sulfamethoxazole
(Bactrim), cipro£oxacin, amoxycillin/clavulanic acid (Aug-
mentin), clarithromycin, and cefoperazone.
Table1 summarizes all results and reveals the following
trends.
Considerable di¡erences in the incidence of resistance
between clinical and food isolates are only detected for peni-
cillin, ampicillin and cipro£oxacin (resistance higher in clini-
cal isolates).
No relevant chronological variation in susceptibility is
detected in clinical isolates in the period 1994^97, except for a
tendency for erythromycin resistance to increase ( 8.4%).
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Food isolates showed in the last decade a considerable
increase in amoxycillin/clavulanic acid resistance (14.2%)
and erythromycin resistance ( 5.9%), while the increase in
resistance to other antibiotics was less relevant (penicillin/
ampicillin, 3%; clarithromycin, 4.2%; cefoperazone,
2.7%; others, 0%). Further, a considerable decrease of
inhibition diameter in the disk di¡usion test (from 37mm to
22mm) was monitored for amoxycillin/clavulanic acid: from
37mm (1988^89) to 22mm (1998).
The susceptibility to vancomycin and oxacillin (important
antimicrobial agents in Gram-positive infections) was 100%
for all isolates tested, except for an oxacillin-resistant clinical
isolate.
The higher incidence of penicillin, ampicillin and cipro-
£oxacin resistance in the clinical reservoir might be due to a
more substantial antibiotic pressure on Staphylococcus aureus
isolated from humans. Although the ¢rst-line antimicrobial
therapy used in the treatment of bovine mastitis is a combina-
tion of penicillin and neomycin, the use of penicillins is still
prevalent in humans. The increase of erythromycin resistance
in clinical isolates ( 8.4%) can be explained by the heavy use
of this macrolide, while the increase in amoxycillin/clavulanic
acid resistance in food isolates remains unexplained, since this
antimicrobial is prevalent in human medicine. The reduction
of the inhibition diameter observed in agar plates with amox-
ycillin/clavulanic acid disks (from 37 to 22mm in the last dec-
ade) should be further investigated; a possible explanation
might be related to the attenuation of the synergistic action of
the two components.
In conclusion, though the transmission of bovine staphylo-
cocci do not constitute a hazard for humans, the evolution of
antimicrobial resistance in Staphylococcus aureus isolates recov-
ered from dairy products in the southern part of Switzerland
con¢rms, in part, the increasing trend observed in clinical iso-
lates. In particular, the problem of the increase of penicillin
resistance in food isolates should be addressed with more pre-
cise clinical studies aimed to investigate the e¤ciency of anti-
microbial treatments for bovine mastitis. A positive issue
highlighted by this study is certainly the absence of isolates
resistant to vancomycin and oxacillin in nearly both reser-
voirs.
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Table 1 Percentage sensitivity of Staphylococcus aureus strains from three clinical and two food campaigns
Campaigns P AM OX CZ GM D E VA SXT CIP AMC CCa CFPa
Clinical 1994 (n 32) 25 25 100 100 100 96.8 96.8 100 100 87.5 93.7
Clinical 1995 (n 58) 39.6 39.6 98.3 98.3 96.5 98.3 89.6 100 91.4 94.8 96.5
Clinical 1997 (n 69) 20.3 20.3 100 100 98.6 95.7 88.4 100 100 85.5 97.1
Food 1988±89 (n41) 48.8 48.8 100 100 100 97.6 97.6 100 100 100 97.6 100 90.2
Food 1998 (n24) 45.8 45.8 100 100 100 100 91.7 100 100 100 83.4 95.8 87.5
P, penicillin; AM, ampicillin; OX, oxacillin; CZ, cefazolin; GM, gentamicin; D, doxycycline; E, erythromycin; VA, vancomycin; SXT,
trimethoprim/sulfamethoxazole; CIP, cipro¯oxacin; AMC, amoxycillin/clavulanic acid; CC, clarithromycin; CFP, cefoperazone.
aAntibiotics tested for food isolates only.
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